DERMAPHARM HOLDING SE (DMP.DE) Stock Fundamental Analysis

FRA:DMP • DE000A2GS5D8

40.1 EUR
+0.8 (+2.04%)
Last: Feb 27, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

Taking everything into account, DMP scores 5 out of 10 in our fundamental rating. DMP was compared to 52 industry peers in the Pharmaceuticals industry. Both the profitability and the financial health of DMP get a neutral evaluation. Nothing too spectacular is happening here. DMP has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • DMP had positive earnings in the past year.
  • In the past year DMP had a positive cash flow from operations.
  • Each year in the past 5 years DMP has been profitable.
  • Each year in the past 5 years DMP had a positive operating cash flow.
DMP.DE Yearly Net Income VS EBIT VS OCF VS FCFDMP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

  • DMP has a Return On Assets (5.48%) which is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of 17.87%, DMP is in line with its industry, outperforming 59.62% of the companies in the same industry.
  • With a Return On Invested Capital value of 7.26%, DMP perfoms like the industry average, outperforming 44.23% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for DMP is below the industry average of 14.12%.
Industry RankSector Rank
ROA 5.48%
ROE 17.87%
ROIC 7.26%
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
DMP.DE Yearly ROA, ROE, ROICDMP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

  • With a Profit Margin value of 10.00%, DMP perfoms like the industry average, outperforming 42.31% of the companies in the same industry.
  • DMP's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 18.70%, DMP is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • DMP's Operating Margin has improved in the last couple of years.
  • DMP has a Gross Margin of 66.57%. This is comparable to the rest of the industry: DMP outperforms 40.38% of its industry peers.
  • In the last couple of years the Gross Margin of DMP has grown nicely.
Industry RankSector Rank
OM 18.7%
PM (TTM) 10%
GM 66.57%
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
DMP.DE Yearly Profit, Operating, Gross MarginsDMP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so DMP is still creating some value.
  • DMP has about the same amout of shares outstanding than it did 1 year ago.
  • DMP has about the same amout of shares outstanding than it did 5 years ago.
  • The debt/assets ratio for DMP is higher compared to a year ago.
DMP.DE Yearly Shares OutstandingDMP.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
DMP.DE Yearly Total Debt VS Total AssetsDMP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 2.28 indicates that DMP is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • DMP has a Altman-Z score (2.28) which is in line with its industry peers.
  • DMP has a debt to FCF ratio of 6.15. This is a slightly negative value and a sign of low solvency as DMP would need 6.15 years to pay back of all of its debts.
  • DMP has a Debt to FCF ratio (6.15) which is comparable to the rest of the industry.
  • DMP has a Debt/Equity ratio of 1.44. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of DMP (1.44) is worse than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF 6.15
Altman-Z 2.28
ROIC/WACC1.06
WACC6.87%
DMP.DE Yearly LT Debt VS Equity VS FCFDMP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 2.20 indicates that DMP has no problem at all paying its short term obligations.
  • The Current ratio of DMP (2.20) is better than 73.08% of its industry peers.
  • DMP has a Quick Ratio of 1.04. This is a normal value and indicates that DMP is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of DMP (1.04) is better than 61.54% of its industry peers.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 1.04
DMP.DE Yearly Current Assets VS Current LiabilitesDMP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 28.01% over the past year.
  • Measured over the past years, DMP shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.07% on average per year.
  • Looking at the last year, DMP shows a small growth in Revenue. The Revenue has grown by 0.11% in the last year.
  • DMP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.00% yearly.
EPS 1Y (TTM)28.01%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%26.56%
Revenue 1Y (TTM)0.11%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%-5.36%

3.2 Future

  • Based on estimates for the next years, DMP will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.68% on average per year.
  • Based on estimates for the next years, DMP will show a small growth in Revenue. The Revenue will grow by 2.40% on average per year.
EPS Next Y11.31%
EPS Next 2Y10.93%
EPS Next 3Y10.12%
EPS Next 5Y14.68%
Revenue Next Year-0.75%
Revenue Next 2Y1.49%
Revenue Next 3Y2.17%
Revenue Next 5Y2.4%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DMP.DE Yearly Revenue VS EstimatesDMP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
DMP.DE Yearly EPS VS EstimatesDMP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 18.65, which indicates a rather expensive current valuation of DMP.
  • Compared to the rest of the industry, the Price/Earnings ratio of DMP is on the same level as its industry peers.
  • DMP is valuated rather cheaply when we compare the Price/Earnings ratio to 27.10, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 15.93, DMP is valued correctly.
  • 69.23% of the companies in the same industry are more expensive than DMP, based on the Price/Forward Earnings ratio.
  • DMP's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.06.
Industry RankSector Rank
PE 18.65
Fwd PE 15.93
DMP.DE Price Earnings VS Forward Price EarningsDMP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DMP is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of DMP indicates a rather cheap valuation: DMP is cheaper than 82.69% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.13
EV/EBITDA 9.83
DMP.DE Per share dataDMP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.65
PEG (5Y)2.31
EPS Next 2Y10.93%
EPS Next 3Y10.12%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.38%, DMP has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.89, DMP pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.80, DMP pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.38%

5.2 History

  • The dividend of DMP has a limited annual growth rate of 2.71%.
Dividend Growth(5Y)2.71%
Div Incr Years1
Div Non Decr Years1
DMP.DE Yearly Dividends per shareDMP.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

  • 41.76% of the earnings are spent on dividend by DMP. This is a bit on the high side, but may be sustainable.
  • DMP's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP41.76%
EPS Next 2Y10.93%
EPS Next 3Y10.12%
DMP.DE Yearly Income VS Free CF VS DividendDMP.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
DMP.DE Dividend Payout.DMP.DE Dividend Payout, showing the Payout Ratio.DMP.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

DERMAPHARM HOLDING SE

FRA:DMP (2/27/2026, 7:00:00 PM)

40.1

+0.8 (+2.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-13
Earnings (Next)03-17
Inst Owners11.57%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.16B
Revenue(TTM)1.16B
Net Income(TTM)116.03M
Analysts78.18
Price Target42.84 (6.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.38%
Yearly Dividend0.88
Dividend Growth(5Y)2.71%
DP41.76%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)-0.17%
Valuation
Industry RankSector Rank
PE 18.65
Fwd PE 15.93
P/S 1.86
P/FCF 13.13
P/OCF 10.45
P/B 3.33
P/tB N/A
EV/EBITDA 9.83
EPS(TTM)2.15
EY5.36%
EPS(NY)2.52
Fwd EY6.28%
FCF(TTM)3.05
FCFY7.62%
OCF(TTM)3.84
OCFY9.57%
SpS21.55
BVpS12.06
TBVpS-7.73
PEG (NY)1.65
PEG (5Y)2.31
Graham Number24.15
Profitability
Industry RankSector Rank
ROA 5.48%
ROE 17.87%
ROCE 11.89%
ROIC 7.26%
ROICexc 7.91%
ROICexgc 21.74%
OM 18.7%
PM (TTM) 10%
GM 66.57%
FCFM 14.17%
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
ROICexc(3y)10.97%
ROICexc(5y)11.73%
ROICexgc(3y)29.64%
ROICexgc(5y)29.05%
ROCE(3y)16.03%
ROCE(5y)16.96%
ROICexgc growth 3Y-9.69%
ROICexgc growth 5Y2.94%
ROICexc growth 3Y-20.13%
ROICexc growth 5Y-1%
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
F-Score7
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF 6.15
Debt/EBITDA 3.09
Cap/Depr 49.31%
Cap/Sales 3.63%
Interest Coverage 4.01
Cash Conversion 68.3%
Profit Quality 141.71%
Current Ratio 2.2
Quick Ratio 1.04
Altman-Z 2.28
F-Score7
WACC6.87%
ROIC/WACC1.06
Cap/Depr(3y)41.99%
Cap/Depr(5y)70.86%
Cap/Sales(3y)3.57%
Cap/Sales(5y)4.47%
Profit Quality(3y)204.39%
Profit Quality(5y)161.92%
High Growth Momentum
Growth
EPS 1Y (TTM)28.01%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%26.56%
EPS Next Y11.31%
EPS Next 2Y10.93%
EPS Next 3Y10.12%
EPS Next 5Y14.68%
Revenue 1Y (TTM)0.11%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%-5.36%
Revenue Next Year-0.75%
Revenue Next 2Y1.49%
Revenue Next 3Y2.17%
Revenue Next 5Y2.4%
EBIT growth 1Y5.29%
EBIT growth 3Y-8.31%
EBIT growth 5Y13.3%
EBIT Next Year57.22%
EBIT Next 3Y19.63%
EBIT Next 5Y7.01%
FCF growth 1Y-31.18%
FCF growth 3Y-4.81%
FCF growth 5Y24.67%
OCF growth 1Y-25.65%
OCF growth 3Y-7%
OCF growth 5Y14.89%

DERMAPHARM HOLDING SE / DMP.DE FAQ

What is the fundamental rating for DMP stock?

ChartMill assigns a fundamental rating of 5 / 10 to DMP.DE.


Can you provide the valuation status for DERMAPHARM HOLDING SE?

ChartMill assigns a valuation rating of 5 / 10 to DERMAPHARM HOLDING SE (DMP.DE). This can be considered as Fairly Valued.


How profitable is DERMAPHARM HOLDING SE (DMP.DE) stock?

DERMAPHARM HOLDING SE (DMP.DE) has a profitability rating of 5 / 10.


What are the PE and PB ratios of DERMAPHARM HOLDING SE (DMP.DE) stock?

The Price/Earnings (PE) ratio for DERMAPHARM HOLDING SE (DMP.DE) is 18.65 and the Price/Book (PB) ratio is 3.33.


Can you provide the expected EPS growth for DMP stock?

The Earnings per Share (EPS) of DERMAPHARM HOLDING SE (DMP.DE) is expected to grow by 11.31% in the next year.